Spots Global Cancer Trial Database for cis platinum
Every month we try and update this database with for cis platinum cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer | NCT04590625 | Ovarian Cancer | Apatinib Mesyla... Abraxane Cis Platinum Carboplatin | 18 Years - 75 Years | Zhongshan Hospital Xiamen University | |
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC | NCT04153734 | Locally Advance... | Pembrolizumab Cis Platinum Carboplatin Pemetrexed nab paclitaxel | - | Kobe Minimally Invasive Cancer Center | |
Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | NCT05469061 | Esophageal Squa... Locally Advance... | Tislelizumab 5-FU cis Platinum | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC | NCT04153734 | Locally Advance... | Pembrolizumab Cis Platinum Carboplatin Pemetrexed nab paclitaxel | - | Kobe Minimally Invasive Cancer Center | |
Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma | NCT05151588 | Sinonasal Carci... | Docetaxel Cis Platinum 5-FU Tazemetostat Surgery Chemoradiation | 18 Years - | The University of Hong Kong | |
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC | NCT03141359 | Lung Cancer Sta... Lung Cancer Sta... Non Small Cell ... | SBRT Carboplatin Paclitaxel cis Platinum Etoposide IMRT Durvalumab | 18 Years - | Wake Forest University Health Sciences |